Related Experiment Video
Updated: May 31, 2026

10:05
The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Published on: April 28, 2015
Introduction to multiple organ dysfunction and failure.
1Department of Clinical Sciences, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523, USA. Tim.Hackett@colostate.edu
Summary
Multiple organ dysfunction syndrome (MODS) is a critical condition in intensive care, leading to organ failure. Understanding its inflammatory basis and managing it with supportive care is key for patient survival.
Area of Science:
- Critical care medicine
- Veterinary internal medicine
- Pathophysiology
Background:
- Multiple organ dysfunction syndrome (MODS) emerged as a complication of critical care advancements.
- MODS is a primary cause of mortality and resource use in human intensive care units.
- MODS is increasingly recognized in veterinary small animal patients.
Purpose of the Study:
- To review the evolving understanding of MODS pathogenesis.
- To highlight current management strategies for MODS.
- To identify key pathophysiological features of MODS.
Main Methods:
- Literature review of MODS pathogenesis and management.
- Synthesis of information on clinical presentation and features.
- Analysis of the shift in understanding from infection to inflammation.
Main Results:
- The understanding of MODS pathogenesis has shifted from uncontrolled infection to uncontrolled inflammation.
- Current management relies on supportive care, organ function monitoring, and intensive care.
- Prominent features include tissue hypoxia, microvascular thrombosis, increased vascular permeability, and disrupted cell communication.
Conclusions:
- MODS represents a significant challenge in both human and veterinary critical care.
- Effective management requires a comprehensive approach focusing on supportive care and monitoring.
- Further research into the inflammatory pathways of MODS is warranted.
Related Concept Videos
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Cellular Injury I: Introduction
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
